$MBRX News Article - Moleculin Announces Positive
Post# of 27118
(Total Views: 238)
Posted On: 11/13/2023 10:50:52 AM
$MBRX News Article - Moleculin Announces Positive Interim Data in Annamycin Clinical Trials: MB-106 AML Trial Complete Response (CR) Rate of 38% and MB-107 STS Lung Mets Trial Median Phase 1B Extended Overall Survival of 11 Months https://marketwirenews.com/news-releases/mole...62053.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼